AU7083700A - Methods for assaying mitochondrial intermembrane space protein translocation - Google Patents

Methods for assaying mitochondrial intermembrane space protein translocation

Info

Publication number
AU7083700A
AU7083700A AU70837/00A AU7083700A AU7083700A AU 7083700 A AU7083700 A AU 7083700A AU 70837/00 A AU70837/00 A AU 70837/00A AU 7083700 A AU7083700 A AU 7083700A AU 7083700 A AU7083700 A AU 7083700A
Authority
AU
Australia
Prior art keywords
methods
protein translocation
intermembrane space
mitochondrial intermembrane
space protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70837/00A
Inventor
Alexander Y. Andreyev
Anne N. Murphy
Sandra Eileen Wiley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Migenix Corp
Original Assignee
Mitokor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitokor Inc filed Critical Mitokor Inc
Publication of AU7083700A publication Critical patent/AU7083700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • G01N33/5079Mitochondria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5035Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on sub-cellular localization
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058Neurological cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU70837/00A 1999-08-27 2000-08-28 Methods for assaying mitochondrial intermembrane space protein translocation Abandoned AU7083700A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US15123199P 1999-08-27 1999-08-27
US60151231 1999-08-27
US16950899P 1999-12-07 1999-12-07
US60169508 1999-12-07
US60637000A 2000-06-28 2000-06-28
US09606370 2000-06-28
PCT/US2000/023638 WO2001016373A2 (en) 1999-08-27 2000-08-28 Assaying of mitochondrial intermembrane space protein translocation

Publications (1)

Publication Number Publication Date
AU7083700A true AU7083700A (en) 2001-03-26

Family

ID=27387098

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70837/00A Abandoned AU7083700A (en) 1999-08-27 2000-08-28 Methods for assaying mitochondrial intermembrane space protein translocation

Country Status (2)

Country Link
AU (1) AU7083700A (en)
WO (1) WO2001016373A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2566516A (en) 2017-09-15 2019-03-20 Univ Oxford Innovation Ltd Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996026276A1 (en) * 1995-02-22 1996-08-29 THE GOVERNMENT OF THE UNITED STATES OF AMERICA,_represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES SecA GENE OF MYCOBACTERIUM TUBERCULOSIS AND RELATED METHODS AND COMPOSITIONS
US5856160A (en) * 1997-03-31 1999-01-05 Incyte Pharmaceuticals, Inc. Mitochondrial adenylate kinase
EP1047939B1 (en) * 1998-01-08 2004-10-06 BioImage A/S Method and apparatus for high density format screening for bioactive molecules
US20030044776A1 (en) * 1998-09-25 2003-03-06 James A. Dykens Compositions and methods for identifying agents that alter mitochondrial permeability transition pores
EP1131434B1 (en) * 1998-11-23 2006-10-18 Centre National de la Recherche Scientifique Apoptosis-inducing factor
US6110691A (en) * 2000-01-06 2000-08-29 Board Of Regents, The University Of Texas System Activators of caspases

Also Published As

Publication number Publication date
WO2001016373A2 (en) 2001-03-08
WO2001016373A3 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
AU7676700A (en) Identification system
AU2001243227A1 (en) Remote-to-remote position locating system
AU3206900A (en) Position sensing system
AU2434199A (en) Protein
AU3440900A (en) Assay system
AU6045900A (en) Interaction-activated proteins
AU3350800A (en) Protein sweetener
AU5020000A (en) Phospholipid transfer protein
AU6223700A (en) Gtp-binding associated proteins
AU6555900A (en) Transponder system
AU1744900A (en) Gtpase associated proteins
AU4465101A (en) Contents providing system
AU4188500A (en) Protein c derivatives
AU4352000A (en) Clasp-2 transmembrane proteins
AU1751801A (en) Protein c derivatives
AU4214800A (en) Vesicle associated proteins
AU7083700A (en) Methods for assaying mitochondrial intermembrane space protein translocation
AU2579401A (en) Brain protein markers
AU1030100A (en) Beverage for animals
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU4245500A (en) Protein transport assays
AU2538899A (en) Protein kinase c
AU2001244863A1 (en) Apoptin-associating protein
AU2002243234A1 (en) Embryogenesis associated proteins
AU1540701A (en) Novel protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase